Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

FDA Approves Atrisorb Tissue Regeneration Barrier With Doxycycline FORT COLLINS, CO -- September 14, 2000 -- Atrix Laboratories, Inc. announced that the company has received marketing clearance from the U.S. Food and Drug Administration (FDA) for its Atrisorb® FreeFlow guided tissue regeneration (GTR) barrier with the antibiotic doxycycline. The new product advances current GTR therapy by inhibiting microbial growth that can impair healing. Block Drug Corporation has the right to market the new product in the United States. As a result of FDA clearance, Atrix has earned an additional milestone payment from Block. Dr. Steve Garrett, vice president of clinical research, said, "The presence of an antibiotic inhibits bacterial growth on the barrier. This growth has been shown in a number of independent studies to limit clinical improvements. Use of Atrisorb Free Flow barrier with doxycycline resulted in statistically superior reductions in bacterial growth on the barrier for at least six weeks after surgery and barrier placement." Guided tissue regeneration barriers are used during periodontal surgery to help regenerate bone and other tissues destroyed by periodontal disease. The new barrier product incorporates the antibiotic doxycycline in the Atrisorb GTR barrier. The antibiotic is released over a period of seven days following surgery. "This has the potential to be another excellent added revenue generator for Atrix as we increase and expand the market for our dental products in the U.S. and Europe," said David R. Bethune, chairman and chief executive officer of Atrix. Related Link: Atrix Laboratories, Inc. E-mail this page to a friend or colleague! To print, use this version